HomeInsightsStock Comparison

International Gemmological Institute India Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

International Gemmological Institute India Ltd vs Onesource Specialty Pharma Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of International Gemmological Institute (India) Ltd is ₹ 398.05 as of 16 Jul 15:30.
  • The p/e ratio of International Gemmological Institute (India) Ltd changed from 56 to 0 over 6 quarters. This represents a CAGR of -100.00% The p/e ratio of OneSource Specialty Pharma Ltd changed from 0 to 0 over 8 quarters. This represents a CAGR of 0.0% .
  • The market cap of International Gemmological Institute (India) Ltd changed from ₹ 23917 crore to ₹ 0 crore over 6 quarters. This represents a CAGR of -100.00% The market cap of OneSource Specialty Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The revenue of International Gemmological Institute (India) Ltd for the Jun '25 is ₹ 313.22 crore as compare to the Mar '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of OneSource Specialty Pharma Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 428.84 crore. This represent the decline of -100%.
  • The ebitda of International Gemmological Institute (India) Ltd for the Jun '25 is ₹ 204.13 crore as compare to the Mar '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of OneSource Specialty Pharma Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 184.72 crore. This represent the decline of -100%.
  • The net profit of International Gemmological Institute (India) Ltd changed from ₹ 126.08 crore to ₹ 140.73 crore over 6 quarters. This represents a CAGR of 7.60% The net profit of OneSource Specialty Pharma Ltd changed from ₹ -107 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of International Gemmological Institute (India) Ltd changed from 24.01 % on December 2024 to 0 % on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of OneSource Specialty Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 10 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About International Gemmological Institute (India) Ltd

  • International Gemological Institute India Limited was incorporated as International Gemmological Institute (India) Private Limited' at Mumbai, Maharashtra as a Private Limited Company, pursuant to a Certificate of Incorporation dated February 23, 1999, issued by the Registrar of Companies, Maharashtra at Mumbai, which subsequently got converted to Public Limited Company and the name of Company has changed to International Gemmological Institute (India) Limited' vide fresh Certificate of Incorporation dated July 10, 2024 issued by the RoC. IGI India is part of the International Gemmological Institute (IGI) Group.
  • The primary business is the provision of services related to the certification and accreditation of natural diamonds, laboratory grown diamonds, studded jewelry and colored stones as well as educational programs.

About OneSource Specialty Pharma Ltd

  • Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore.
  • The Company name was then changed to Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
  • The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as Stelis Biopharma Limited' dated July 31, 2021,.
  • Subsequently, the name was changed to its present Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.

International Gemmological Institute (India) Ltd News Hub

News

International Gemmological Institute(I)L to convene AGM

International Gemmological Institute(I)L announced that the 27th Annual General Meeting(AG...

Read more

09 Jun 2025 14:53

News

Intl Gemmological Institute hits the roof after Q1 PAT jumps 12% YoY to Rs 141 cr

Profit before tax (PBT) stood at Rs 191.47 crore in Q1 CY25, up 11.91% YoY. Total expenses...

Read more

21 Apr 2025 12:32

News

International Gemmological Institute(I)L announces board meeting date

International Gemmological Institute(I)L will hold a meeting of the Board of Directors of ...

Read more

15 Apr 2025 10:13

News

Board of International Gemological Institute recommends Interim Dividend

International Gemological Institute announced that the Board of Directors of the Company a...

Read more

22 Feb 2025 14:53

News

International Gemological Institute I.Lt to consider Interim Dividend

International Gemological Institute I.Lt will hold a meeting of the Board of Directors of ...

Read more

20 Feb 2025 10:20

News

International Gemological Institute I.Lt announces board meeting date

International Gemological Institute I.Lt will hold a meeting of the Board of Directors of ...

Read more

18 Feb 2025 12:56

OneSource Specialty Pharma Ltd News Hub

News

OneSource collaborates with Xbrane Biopharma AB

OneSource Specialty Pharma and Xbrane Biopharma AB, a Sweden-headquartered biotechnology c...

Read more

11 Jun 2025 09:07

News

Onesource Specialty edges higher after inking manufacturing pact with biotech firm Xbrane

Xbrane Biopharma AB is a biotechnology company. It develops biological drugs based on a pa...

Read more

11 Jun 2025 10:09

News

OneSource Specialty jumps as Bangalore facility passes USFDA check

The facility received a Voluntary Action Indicated (VAI) classification from the USFDA, fo...

Read more

10 Jun 2025 10:16

News

OneSource receives ratings action from India Ratings & Research

OneSource Specialty Pharma announced that India Ratings & Research has assigned the credit...

Read more

04 Jun 2025 12:48

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

30 Apr 2025 11:35

News

OneSource Specialty Pharma to convene board meeting

OneSource Specialty Pharma will hold a meeting of the Board of Directors of the Company on...

Read more

25 Jan 2025 10:23

SWOT Analysis Of OneSource Specialty Pharma Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of International Gemmological Institute (India) Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

FAQs for the comparison of International Gemmological Institute (India) Ltd and OneSource Specialty Pharma Ltd

Which company has a larger market capitalization, International Gemmological Institute (India) Ltd or OneSource Specialty Pharma Ltd?

Market cap of International Gemmological Institute (India) Ltd is 17,202 Cr while Market cap of OneSource Specialty Pharma Ltd is 22,604 Cr

What are the key factors driving the stock performance of International Gemmological Institute (India) Ltd and OneSource Specialty Pharma Ltd?

The stock performance of International Gemmological Institute (India) Ltd and OneSource Specialty Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for International Gemmological Institute (India) Ltd and OneSource Specialty Pharma Ltd?

As of July 16, 2025, the International Gemmological Institute (India) Ltd stock price is INR ₹398.05. On the other hand, OneSource Specialty Pharma Ltd stock price is INR ₹1974.8.

How do dividend payouts of International Gemmological Institute (India) Ltd and OneSource Specialty Pharma Ltd compare?

To compare the dividend payouts of International Gemmological Institute (India) Ltd and OneSource Specialty Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions